Dianthus Therapeutics (DNTH) PT Raised to $130 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $93.34 --0%
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 20 | New: 48
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 20 | New: 48
Join SI Premium – FREE
H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $130.00 (from $47.00) while maintaining a Buy rating.
You May Also Be Interested In
- Intercontinental Exchange (ICE) PT Lowered to $190 at UBS Following June Metrics Release
- Regions Financial (RF) PT Raised to $33 at UBS
- Synchrony Financial (SYF) PT Raised to $84 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
